Beijing Leadman Biochemistry Co Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Beijing Leadman Biochemistry Co Ltd with three other
companies in this sector in China:
Beijing Strong Biotechnologies Inc
sales of 694.28 million Chinese Renmimbi [US$101.25 million]
of which 92%
was In Vitro Test Reagents),
Getein Biotech Inc
(488.58 million Chinese Renmimbi [US$71.25 million]
of which 99%
was In-vitro diagnostics), and
Guangdong Hybribio Biotech Co Ltd
(479.09 million Chinese Renmimbi [US$69.87 million]
of which 97%
was Monitoring Instrument).
Beijing Leadman Biochemistry Co Ltd reported sales of 575.98 million Chinese Renmimbi (US$84.00 million)
December of 2017.
increase of 8.0%
versus 2016, when the company's sales were 533.39 million Chinese Renmimbi.
Despite this increase, sales are still
below the level achieved in 2015, when Beijing Leadman Biochemistry Co Ltd
reported sales of 681.68 million Chinese Renmimbi.